dipentum olsalazine sodium capsule gelatin coated
alaven pharmaceutical llc - olsalazine sodium (unii: y7jew0xg7i) (olsalazine - unii:uls5i8j03o) - olsalazine sodium 250 mg
dipentum olsalazine sodium 500mg tablet bottle
atnahs pharma australia pty ltd - olsalazine sodium, quantity: 500 mg - tablet, uncoated - excipient ingredients: povidone; crospovidone; colloidal anhydrous silica; magnesium stearate; ethanol - indications: treatment of ulcerative colitis in patients intolerant of sulphasalazine.
dipentum 250mg hard capsules
atnahs pharma netherlands b.v. - olsalazine sodium - capsule, hard - 250 milligram(s) - aminosalicylic acid and similar agents; olsalazine
dipentum capsule
atnahs pharma uk limited - olsalazine sodium - capsule - 250mg - olsalazine sodium 250mg - anti-inflammatory agents
dipentum 250mg capsules
atnahs pharma australia pty ltd - olsalazine sodium, quantity: 250 mg - capsule - excipient ingredients: titanium dioxide; gelatin; magnesium stearate; caramel; propylene glycol; butan-1-ol; isopropyl alcohol; strong ammonia solution; iron oxide black; ethanol; shellac; sulfuric acid; purified water; industrial methylated spirit; ammonia - indications as at 19 december 2000: treatment of ulcerative colitis in patients intolerant of sulphasalazine.
dipentum olsalazine sodium capsule
ucb, inc. - olsalazine sodium (unii: y7jew0xg7i) (olsalazine - unii:uls5i8j03o) - 250 mg
olsalazine 250mg capsules
medihealth (northern) ltd - olsalazine sodium - oral capsule - 250mg
dipentum
clinect nz pty limited - olsalazine sodium 500mg (plus overage 1.2%) - tablet - 500 mg - active: olsalazine sodium 500mg (plus overage 1.2%) excipient: colloidal silicon dioxide crospovidone magnesium stearate povidone
dipentum 250mg hard capsules
atnahs pharma uk limited - olsalazine sodium - capsule - 250 milligram(s) - aminosalicylic acid and similar agents; olsalazine
olsalazine 500mg tablets
atnahs pharma uk ltd - olsalazine sodium - oral tablet - 500mg